	Development of Benchmark Values for Evaluating Outcomes in Patients Undergoing Gallbladder Cancer Surgery in China: A Multicenter Retrospective Cohort Study. J Gastrointest Surg Wang RY, Dong BW, Luo YL, Pan Y, Lu L, Zhang D, Qu K, Guo W, Lan X, Jin S, Wang ZR, Zhu Y, Yin DL, Zhang L, Yin XY, Bai J, Jiang Y, Dai HS, Chen ZY, Sun TG, Liu ZP. PMID: 42754215 [PubMed - as supplied by publisher]
	KMT2D, a key factor in driving cellular transformation and influencing therapeutic response across cancer lineages. Crit Rev Oncol Hematol Sahu P, Lee YT, Karatza A, Tan YJ, Huang HY, So J, Wong KK. PMID: 42754127 [PubMed - as supplied by publisher]
	Pharmacological intersections between type 2 diabetes and cancer: metabolic crosstalk, antidiabetic therapies, and clinical implications. Pharmacol Res Liu D, Xie D, Che X, Li X, Xu W, Wu G. PMID: 42753877 [PubMed - as supplied by publisher]
	Nationwide Fully Decentralized Telemedicine Therapeutic Trial for Advanced Pancreatic Cancer: Implementation and First Enrollment. JCO Precis Oncol Risch ZA, Reeser JW, Wing MR, Jackman C, Bushong B, Smith A, Dao T, Samorodnitsky E, Pan X, Gupta A, Roychowdhury S. PMID: 42753219 [PubMed - in process]
	Determining malignant potential of pancreatic intraductal papillary mucinous neoplasm with CT: interobserver variability and diagnostic performance. Abdom Radiol (NY) Lee J, Choi SY, Kim JH, Han NY, Park M, Jang HS, Kim CS, Ju SG, Moon JE, Min JH. PMID: 42752962 [PubMed - as supplied by publisher]
	Undifferentiated Carcinoma of the Pancreas With Osteoclast-Like Giant Cells: A Comprehensive Review of Clinical Features, Molecular Pathology, and Therapeutic Advances. Int J Surg Pathol Zhang K. PMID: 42752286 [PubMed - as supplied by publisher]
	Pancreatic Cancer Screening and Early Detection: Where Are We Now? Radiographics Srinivas Rao S, Ghosh S, Goenka AH, Hecht EM, Huang C, Wang ZJ, Fernández-Del Castillo C, Chung DC, Chari ST, Kambadakone AR. PMID: 42752241 [PubMed - indexed for MEDLINE]
	Association of week-2 Contrast-Enhanced Ultrasound Perfusion Changes with Response to Lenvatinib Plus PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study. J Hepatocell Carcinoma Su H, Gao Y, Zhang S, Wen PH. PMID: 42751325 [PubMed]
	Key Mucins in Early Diagnosis of Pancreatic Ductal Adenocarcinoma and Biliary Tract Cancer: A Meta-Analysis. Phenomics Cai F, Gu Y, Gao J, Yi G, Zhang Y. PMID: 42750737 [PubMed]
	RAS-targeted therapies for pancreatic cancer. ESMO Gastrointest Oncol Chan LL, Kwong TT, Yau JCW, Chan SL. PMID: 42750735 [PubMed]
	Decoding neuro-tumor interactions in pancreatic cancer: mechanisms, immunosuppressive networks and therapeutic opportunities. Mol Biomed Cheng W, Cao H, Hu H, Qian R, Xu B, Zhang J. PMID: 42749962 [PubMed - indexed for MEDLINE]
	Microsomal glutathione transferase 1: A master regulator of ferroptosis in cancer and beyond. Adv Cancer Res Zhang X, Ye ZW, Townsend DM, Tew KD, Zhang J. PMID: 42749385 [PubMed - indexed for MEDLINE]
	Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer. Cancer Cell Shi S, Wei M, Du N, Li J, Han B, Wang W, Hu X, Luo F, Xu J, Yu X. PMID: 42748921 [PubMed - as supplied by publisher]
	Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase II study (GeNeS1S trial). Eur J Cancer Nagatani Y, Chayahara N, Satake H, Yasui H, Sugimoto T, Toyama H, Tobimatsu K, Ito E, Usui Y, Koyama T, Kimbara S, Imamura Y, Funakoshi Y, Toyoda M, Kiyota N, Minami H. PMID: 42748587 [PubMed - as supplied by publisher]
	Renal-clearable fluorescent probe for early detection of pancreatic cancer in living murine models. Sci Adv Huang M, Zhou Z, Zhang T, Xia X, Chen W, Wang E, Wang F, Ren J. PMID: 42748261 [PubMed - indexed for MEDLINE]
	[S3 guidelines on exocrine pancreatic cancer 2024 : Consequences for the surgical practice]. Chirurgie (Heidelb) Hank T, Loos M, Michalski C. PMID: 42747481 [PubMed - as supplied by publisher]
	Prevalence of cancer survivors diagnosed within the past 20Â years accounts for 6%: a population-based study in Hiroshima, Japan. Jpn J Clin Oncol Sugiyama H, Hori M, Utada M, Honda T, Matsuda T, Nagata C. PMID: 42747039 [PubMed - as supplied by publisher]
	Targeting drug efflux in pancreatic cancer: what the PANTAX trial teaches us about resisting resistance. Ann Pancreat Cancer Abdel-Razeq N, Mukhopadhyay D, Babiker H. PMID: 42746509 [PubMed]
	Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap. Front Oncol Gu Y, Luo X, Zhang Y, Tang J, Wang Z. PMID: 42746379 [PubMed]
	Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study. Cancer Persano M, Casadei-Gardini A, Fornaro L, Satake T, Abidoye O, Lo Prinzi F, Antonuzzo L, Kim JW, Bergamo F, Bathon M, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Niger M, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Lamarca A, Giordano G, Finkelmeier F, Oneda E, Avallone A, Perkhofer L, Kim IH, Garajova I, Corallo S, Fenocchio E, Dell'Aquila E, Pirrone C, Lucidi L, Tesini G, Valenzi E, Diana A, Yoo C, Schirripa M, Formica V, Rodriquenz MG, Scartozzi M, Adeva J, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan SL, Ikeda M, Bekaii-Saab T, Lucchetti J, Lavacchi D, Kang M, Balsano R, Salani F, Camera S, Masi G, Lonardi S, Vogel A, Rimassa L, Rimini M. PMID: 42745498 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 61561

Page 1 of 3079



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy